All bills
S. 5383·119th Congress·Senate Bill

End Gas Station Heroin Act

IntroducedTrack

Latest action (8 Aug 2026): Introduced

What this bill does

S. 5383, introduced in the Senate on August 8, 2026, by Sen. Bernie Moreno (R-OH), would amend the Controlled Substances Act to classify several kratom-derived compounds as controlled substances. Specifically, it would place MGM-15 and MGM-16 into Schedule I, and would schedule synthetic 7-hydroxymitragynine and mitragynine pseudoindoxyl as Schedule I substances above a specified threshold amount. The bill would also expand enforcement authority against manufacturers and distributors of these and similar emerging synthetic opioid products, sometimes referred to as "gas station heroin."

The bill would primarily affect manufacturers, distributors, and retailers of products containing these compounds, as well as federal drug enforcement agencies tasked with regulating and prosecuting violations. Consumers and sellers of kratom-derived or synthetic opioid-like products could also be affected depending on how the substances are ultimately defined and enforced.

The bill's full legislative text has not yet been published, so the specific thresholds, definitions, and enforcement mechanisms are not yet publicly available. As of the latest action on August 8, 2026, the bill has only been introduced in the Senate. Next steps would typically include referral to a Senate committee, such as the Judiciary Committee, for review before any further action, such as a committee vote or floor consideration, could occur.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.

Official summary

This bill is in the first stage of the legislative process. It was introduced into Congress on August 8, 2026. It will typically be considered by committee next before it is possibly sent on to the House or Senate as a whole.

Common questions

What does S. 5383 do?
S. 5383, introduced in the Senate on August 8, 2026, by Sen. Bernie Moreno (R-OH), would amend the Controlled Substances Act to classify several kratom-derived compounds as controlled substances. Specifically, it would place MGM-15 and MGM-16 into Schedule I, and would schedule synthetic 7-hydroxymitragynine and mitragynine pseudoindoxyl as Schedule I substances above a specified threshold amount. The bill would also expand enforcement authority against manufacturers and distributors of these and similar emerging synthetic opioid products, sometimes referred to as "gas station heroin." The bill would primarily affect manufacturers, distributors, and retailers of products containing these compounds, as well as federal drug enforcement agencies tasked with regulating and prosecuting violations. Consumers and sellers of kratom-derived or synthetic opioid-like products could also be affected depending on how the substances are ultimately defined and enforced. The bill's full legislative text has not yet been published, so the specific thresholds, definitions, and enforcement mechanisms are not yet publicly available. As of the latest action on August 8, 2026, the bill has only been introduced in the Senate. Next steps would typically include referral to a Senate committee, such as the Judiciary Committee, for review before any further action, such as a committee vote or floor consideration, could occur.
Has S. 5383 become law?
Not yet. As of 8 Aug 2026, S. 5383 is introduced.
Who sponsored S. 5383?
S. 5383 was sponsored by Sen. Bernie Moreno [R-OH] (Republican-OH), with 0 cosponsors.
What's the latest action on S. 5383?
Introduced (8 Aug 2026).

Related bills in Crime and Law Enforcement

Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.